1. Integrating metabolomics into the diagnosis and investigation of anthelmintic resistance.
- Author
-
Shaver AO and Andersen EC
- Subjects
- Animals, Nematoda drug effects, Nematoda genetics, Nematode Infections drug therapy, Nematode Infections parasitology, Nematode Infections veterinary, Nematode Infections diagnosis, Humans, Drug Resistance genetics, Metabolomics, Anthelmintics pharmacology, Anthelmintics therapeutic use, Caenorhabditis elegans genetics, Caenorhabditis elegans drug effects, Caenorhabditis elegans metabolism
- Abstract
Anthelmintic resistance (AR) in parasitic nematodes poses a global health problem in livestock and domestic animals and is an emerging problem in humans. Consequently, we must understand the mechanisms of AR, including target-site resistance (TSR), in which mutations affect drug binding, and non-target site resistance (NTSR), which involves alterations in drug metabolism and detoxification processes. Because much of the focus has been on TSR, NTSR has received less attention. Here, we describe how metabolomics approaches using Caenorhabditis elegans offer the ability to disentangle nematode drug metabolism, identify metabolic changes associated with resistance, uncover novel biomarkers, and enhance diagnostic methods., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF